The US Food and Drug Administration has reminded doctors of the precautions needed with mitoxantrone hydrochloride, sold as Novantrone. In patients treated with it, the heart's pumping strength (left ventricular ejection fraction) should be measured before treatment starts and before every dose, and patients should be watched afterwards for delayed heart damage. Patients with multiple sclerosis receiving the drug should be told about this possible effect.
0
Like
0
Love
0
Angry
0
Dislike
0
